论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Li R, Wang W, Wang Y, Peters S, Zhang X, Li H
Received 22 November 2018
Accepted for publication 6 March 2019
Published 10 April 2019 Volume 2019:15 Pages 883—894
DOI https://doi.org/10.2147/NDT.S195562
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 2
Editor who approved publication: Dr Yu-Ping Ning
Objective: To
investigate effects of early HIV infection and combination antiretroviral
therapy (cART) on intrinsic brain activity by using amplitude of low-frequency
fluctuation (ALFF) analysis.
Patients and methods: Forty-nine
HIV patients, including 26 with cART (HIV+/cART+) and 23 treatment-naïve
(HIV+/cART–), and 25 matched healthy controls (HCs) underwent resting-state
functional magnetic resonance imaging examination. ALFF values were compared by
using one-way ANOVA tests with Analysis of Functional NeuroImages (AFNI)’s
3dClustSim correction (voxel p <0.005, α<0.05). In addition, the ALFF values
of brain regions that showed significant differences among the three groups
were correlated with clinical and neuropsychological variables in both groups
of patients by using Spearman correlation analysis.
Results: ANOVA
analysis showed that statistic difference of ALFF values among three groups was
located in the occipital cortex. Post hoc analysis showed a decrease in
occipital ALFF value in HIV patients compared to HC, but showed no difference
of occipital ALFF between HIV+/cART+ and HIV+/cART–. Additionally, compared
with HC, HIV+/cART+ exhibited higher ALFF in the right caudate and
frontoparietal cortex, and HIV+/cART- showed higher ALFF in the bilateral
caudate. HIV+/cART+ demonstrated higher ALFF values in auditory cortex than
HIV+/cART–. Moreover, ALFF values in the right occipital cortex were positively
associated with CD4+/CD8+ ratio and
executive function in HIV+/cART–.
Conclusion: Early
HIV-infected individuals presented reduced spontaneous brain activity in the
occipital cortex. cART appeared to be ineffective in halting the HIV-induced
neurodegeneration but might delay the progression of neural dysfunction to some
extent. ALFF might be a potential biomarker in monitoring the effects of HIV
and cART on brain function.
Keywords: HIV,
brain, cognitive function, highly active antiretroviral therapy, fMRI